The US authorities have announced plans to directly allocate US$3.2 billion to accelerate the development of antiviral drugs for the corona and other future viral diseases.
The project is called the “anti-virus plan to fight the pandemic,” and its funding comes from the $1.9 trillion recovery plan passed by Congress in March.
White House scientific adviser Anthony Fauci told reporters: “Antiviral drugs are an adjunct to existing vaccines, especially for those with diseases that put them at additional risk, and those who may be less protected by vaccines. “
Fauci added that these antiviral drugs can also play an important role when it comes to new variants of viruses that provide less protection from existing vaccines.
The plan will make it possible to accelerate the clinical trials of antiviral drugs in different stages of development, such as Merck Laboratories Molnupiravir and Pfizer, and Atea-Roche drugs. Once approved, the rule is that patients start taking it immediately after confirming the infection to prevent the disease from entering a more serious stage.
This US$3.2 billion will also be used to fund research on new antiviral drugs, not only against the coronavirus, but also against other virus families that may pose a potential pandemic threat.